232 related articles for article (PubMed ID: 15607729)
21. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
Streetz KL; Tacke F; Leifeld L; Wüstefeld T; Graw A; Klein C; Kamino K; Spengler U; Kreipe H; Kubicka S; Müller W; Manns MP; Trautwein C
Hepatology; 2003 Jul; 38(1):218-29. PubMed ID: 12830005
[TBL] [Abstract][Full Text] [Related]
22. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.
Hammacher A; Wijdenes J; Hilton DJ; Nicola NA; Simpson RJ; Layton JE
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):25-32. PubMed ID: 10600635
[TBL] [Abstract][Full Text] [Related]
23. Establishment of the ELISA for murine soluble gp130, a signal transducer for the IL-6 family cytokine, and its detection in the ascitic fluids of tumor-bearing mice.
Matsuda T; Hirano T
Biochem Biophys Res Commun; 1994 Jul; 202(1):637-42. PubMed ID: 8037770
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
25. [Soluble IL-6 receptors].
Jabłońska E
Postepy Hig Med Dosw; 1998; 52(2):133-8. PubMed ID: 9640977
[TBL] [Abstract][Full Text] [Related]
26. Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation.
May P; Schniertshauer U; Gerhartz C; Horn F; Heinrich PC
Acta Biochim Pol; 2003; 50(3):595-601. PubMed ID: 14515142
[TBL] [Abstract][Full Text] [Related]
27. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
28. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD.
Memoli B; Grandaliano G; Soccio M; Postiglione L; Guida B; Bisesti V; Esposito P; Procino A; Marrone D; Michael A; Andreucci M; Schena FP; Pertosa G
J Am Soc Nephrol; 2005 Apr; 16(4):1099-107. PubMed ID: 15716332
[TBL] [Abstract][Full Text] [Related]
29. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF
Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315
[TBL] [Abstract][Full Text] [Related]
30. [Construction of membrane-anchored interleukin-6 receptor beta subunit mutant and its effect on IL-6 signal transduction].
Yang Z; Ni C; Shen B; Wang J; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):632-5. PubMed ID: 11877037
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 trans-signalling in chronic inflammation and cancer.
Scheller J; Ohnesorge N; Rose-John S
Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
[TBL] [Abstract][Full Text] [Related]
32. IL-6 signal transduction and its physiological roles: the signal orchestration model.
Kamimura D; Ishihara K; Hirano T
Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
[TBL] [Abstract][Full Text] [Related]
33. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.
Boulanger MJ; Chow DC; Brevnova EE; Garcia KC
Science; 2003 Jun; 300(5628):2101-4. PubMed ID: 12829785
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
35. Activation of Stat3 by cytokine receptor gp130 ventralizes Xenopus embryos independent of BMP-4.
Nishinakamura R; Matsumoto Y; Matsuda T; Ariizumi T; Heike T; Asashima M; Yokota T
Dev Biol; 1999 Dec; 216(2):481-90. PubMed ID: 10642787
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling.
Zhang P; Chebath J; Lonai P; Revel M
Stem Cells; 2004; 22(3):344-54. PubMed ID: 15153611
[TBL] [Abstract][Full Text] [Related]
37. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of gp130 and STAT3 activation in the rat hippocampus following transient forebrain ischemia.
Choi JS; Kim SY; Cha JH; Choi YS; Sung KW; Oh ST; Kim ON; Chung JW; Chun MH; Lee SB; Lee MY
Glia; 2003 Feb; 41(3):237-46. PubMed ID: 12528179
[TBL] [Abstract][Full Text] [Related]
39. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.
Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J
Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310
[TBL] [Abstract][Full Text] [Related]
40. [gp130F759 mouse].
Ishihara K; Hirano T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():68-72. PubMed ID: 15799320
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
